CSPC Innovation Pharmaceutical Co Ltd Class A (300765) — Cash Flow-to-Debt Ratio
CSPC Innovation Pharmaceutical Co Ltd Class A (300765) has a Cash Flow-to-Debt Ratio of -0.01x as of December 2025, meaning its operating cash flow of CN¥-25.98 Million could theoretically repay 0% of its total liabilities (CN¥3.48 Billion) in one year. See 300765 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CSPC Innovation Pharmaceutical Co Ltd Class A Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for CSPC Innovation Pharmaceutical Co Ltd Class A across 12 annual periods. For the full cash flow conversion analysis, see 300765 operating cash flow.
Annual Cash Flow-to-Debt Ratio for CSPC Innovation Pharmaceutical Co Ltd Class A (2014–2025)
Year-by-year debt coverage analysis for CSPC Innovation Pharmaceutical Co Ltd Class A. Check CSPC Innovation Pharmaceutical Co Ltd Cl cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.06x | CN¥-195.69 Million | CN¥3.48 Billion | ▲ +93.1% |
| 2024 | -0.81x | CN¥-1.24 Billion | CN¥1.53 Billion | ▼ -273.6% |
| 2023 | 0.47x | CN¥927.24 Million | CN¥1.99 Billion | ▼ -53.4% |
| 2022 | 1.00x | CN¥640.72 Million | CN¥639.84 Million | ▲ +52.1% |
| 2021 | 0.66x | CN¥292.09 Million | CN¥443.58 Million | ▼ -49.1% |
| 2020 | 1.29x | CN¥349.07 Million | CN¥269.65 Million | ▲ +79.4% |
| 2019 | 0.72x | CN¥315.38 Million | CN¥437.06 Million | ▲ +76.8% |
| 2018 | 0.41x | CN¥159.73 Million | CN¥391.45 Million | ▲ +11265.5% |
| 2017 | 0.00x | CN¥1.30 Million | CN¥362.16 Million | ▼ -99.0% |
| 2016 | 0.35x | CN¥137.27 Million | CN¥396.66 Million | ▲ +2.0% |
| 2015 | 0.34x | CN¥112.05 Million | CN¥330.20 Million | ▲ +7.1% |
| 2014 | 0.32x | CN¥93.36 Million | CN¥294.66 Million | — |